Abstract
This chapter discusses the profound impact personalised medicine is expected to have on public healthcare systems. First, introducing personalised medicine will radically affect the healthcare value chain and stages in which the healthcare system plays the key role, namely in the form of lifelong care for a person’s healthy life. Public healthcare networks will become increasingly international. Second, in the current situation, out-of-pocket payment is the most reasonable way of financing personalised medicine, but the future development of personalised medicine will depend on health insurance that resembles life insurance. Third, it is possible to ground collective financing only on solidarity and not on the differences between social and individual effects. Fourth, personalised medicine requires a great deal of state regulation. Fifth, personalised medicine is based on a large volume of information and only the individual should have the right to decide how this information is used.
This chapter addresses the relationship between personalised medicine and the public healthcare system. It is based on the hypothesis that the development of personalised medicine will call for a radical change in the foundations of public healthcare systems across the world.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
Jain (2015).
- 3.
Official Journal of the European Union, 2015/C 421/03.
- 4.
Jain (2015).
- 5.
Carlsten et al. (2014).
- 6.
Bieber (2013).
- 7.
Jakka and Rossbach (2013).
- 8.
Jakka and Rossbach (2013).
- 9.
Jain (2015).
- 10.
- 11.
- 12.
Sagan and Thomson (2016).
- 13.
Kornai (1986).
- 14.
- 15.
- 16.
Henke and Borchardt (2003).
- 17.
Jakka and Rossbach (2013).
- 18.
Porter and Lee (2013).
- 19.
Xinghua Hu et al. (2005).
- 20.
McPake et al. (2013).
References
Bieber T (2013) Stratified medicine: a new challenge for academia, industry, regulators and patients. Future Medicine Ltd, London
Carande-Kulis VG, Getzen TE, Thacker SB (2007) Public goods and externalities: a research agenda for public health economics. J Public Health Man 13(2):227–232
Carlsten C, Brauer M, Brinkman F, Brook J, Daley D, McNagny K, Pui M, Royce D, Takaro T, Denburg J (2014) Genes, the environment and personalized medicine: we need to harness both environmental and genetic data to maximize personal and population health. EMBO Rep 15(7):736–739
Council conclusions on personalised medicine for patients (2015) Official Journal of the European Union, 2015/C421/03
Henke KD, Borchardt K (2003) Reform proposals for health-care systems. Dice Report 3:3–8
Jain KK (2015) Textbook of personalized medicine. Humana Press, Basel
Jakka S, Rossbach M (2013) An economic perspective on personalized medicine. HUGO J 7(1)
Jegers M, Kesteloot K, De Graeve D, Gilles W (2002) A typology for provider payment systems in health care. Health Policy 60(3):255–273
Kornai J (1986) The soft budget constraint. Kyklos 39(1):3–30
Kornai J, Eggleston K (2001) Welfare, choice, and solidarity in transition. Cambridge University Press, Cambridge
McPake B, Normand C, Smith S (2013) Health economics: an international perspective. Routledge, Abingdon
Meulen R, Arts W, Muffels R (2001) Solidarity, health and social care in Europe: introduction to the volume. In: Meulen R, Arts W, Muffels R (eds) Solidarity in health and social care in Europe. Kluwer, Dordrecht, pp 1–11
Phelps CE (2016) Health economics, 5th edn. Routledge, New York
Porter ME, Lee TH (2013) The strategy that will fix health care. Harv Bus Rev 91(10)
Redekop WK, Mladsi D (2013) The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 16(6 Suppl):S4–S9
Sagan A, Thomson S (2016) Voluntary health insurance in Europe: role and regulation. World Health Organization, European Observatory on Health Systems and Policies, Copenhagen
Saltman RB (2015) Health sector solidarity: a core European value but with broadly varying content. Isr J Health Policy Res 4(5)
Stiglitz JE, Rosengard JK (2015) Economics of the public sector, 4th edn. W.W. Norton, cop., New York, London
Xinghua Hu S, Foster T, Kieffaber A (2005) Pharmacogenomics and personalized medicine: mapping of future value creation. BioTechniques 39(4)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tajnikar, M., Došenović Bonča, P. (2019). Personalised Medicine in Public Healthcare Systems. In: Bodiroga-Vukobrat, N., Rukavina, D., Pavelić, K., Sander, G.G. (eds) Personalized Medicine in Healthcare Systems. Europeanization and Globalization, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-16465-2_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-16465-2_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16464-5
Online ISBN: 978-3-030-16465-2
eBook Packages: Law and CriminologyLaw and Criminology (R0)